0002160182-26-000001.txt : 20261027 0002160182-26-000001.hdr.sgml : 20261027 20261027123121 ACCESSION NUMBER: 0002160182-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20261027 DATE AS OF CHANGE: 20261027 EFFECTIVENESS DATE: 20261027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Wellington Biomedical Innovation III Access Offshore LP CENTRAL INDEX KEY: 0002160182 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-602640 FILM NUMBER: 261488944 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: NEW YORK STATE: NY ZIP: 10282-2198 BUSINESS PHONE: (212) 902-1000 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: NEW YORK STATE: NY ZIP: 10282-2198 D 1 primary_doc.xml X0708 D LIVE 0002160182 Wellington Biomedical Innovation III Access Offshore LP 200 WEST STREET NEW YORK NY NEW YORK 10282-2198 (212) 902-1000 CAYMAN ISLANDS None None Limited Partnership true 2026 Jody Flaws c/o AURUM Governance 14425 Falcon Head Blvd, Building E Austin TX TEXAS 78738 Executive Officer Manager of the Issuer's General Partner Scott Huff c/o Maples Fiduciary Svcs. (DE) Inc. 4001 Kennett Pike, Suite 302 Wilmington DE DELAWARE 19807 Executive Officer Manager of the Issuer's General Partner Richard A. Ruffer c/o Pontis Services Delaware Ltd P.O. Box 677 Far Hills NJ NEW JERSEY 07931 Executive Officer Manager of the Issuer's General Partner Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.7 false true true true false 0 Goldman Sachs & Co. LLC 361 None None 200 West Street New York NY NEW YORK 10282-2198 All States false Indefinite 0 Indefinite false 0 0 0 0 false Wellington Biomedical Innovation III Access Offshore LP /s/ Richard Ruffer Richard Ruffer Manager of the Issuer's General Partner 2026-10-26